Pfizer completes acquisition of Nimenrix and Mencevax from GlaxoSmithKline
- Details
- Category: Pfizer

Genzyme introduces "vs.MS," a global initiative aimed at uncovering the often unspoken challenges of MS to drive better informed care
- Details
- Category: Genzyme

New England Journal of Medicine publishes results of head-to-head studies of brodalumab versus ustekinumab in psoriasis
- Details
- Category: AstraZeneca

New Roche Esbriet data show clinical benefits of continued and long-term treatment in patients with idiopathic pulmonary fibrosis (IPF)
- Details
- Category: Roche

Merck's Consumer Health business counts on Latin America for growth
- Details
- Category: Merck Group

Novartis launches 'Novartis Access', a portfolio of affordable medicines to treat chronic diseases in lower-income countries
- Details
- Category: Novartis

Patients with aggressive form of melanoma lived for more than two years on average when taking Novartis therapies Tafinlar® + Mekinist®
- Details
- Category: Novartis

More Pharma News ...
- Bristol-Myers Squibb and Moffitt Cancer Center enter into a collaboration agreement
- Lilly Diabetes launches new Disney book for families affected by type 1 diabetes
- New Centrum® VitaMints® offer a refreshingly new way to take a multivitamin
- Daiichi Sankyo signs agreement with Translational Sciences, Inc. to develop and commercialize the first-in-class thrombus dissolving agent, TS23
- Abbott is asking one million people worldwide. Here's why and how.
- Boehringer Ingelheim and BioMed X apply crowdsourcing to establish a team of scientists for identifying key epigenetic regulators of COPD
- Bayer aligns organization with Life Science businesses